Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.380
-0.110 (-7.38%)
At close: Aug 1, 2025, 4:00 PM
1.420
+0.040 (2.90%)
After-hours: Aug 1, 2025, 7:59 PM EDT

Chimerix Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Chimerix stock have an average target of 9.00, which predicts a 552.17% increase from the current stock price of 1.38.

Price Target: $9.00 (+552.17%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$9.00$9.00$9.00$9.00
Change+552.17%+552.17%+552.17%+552.17%
* Price targets were last updated on Jun 2, 2025.

Analyst Ratings

The average analyst rating for Chimerix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy333332
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total333332

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$9
Strong BuyInitiates$9+552.17%Jun 2, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong BuyReiterates$9+552.17%Apr 16, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong BuyReiterates$9+552.17%Apr 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong BuyReiterates$9+552.17%Feb 24, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong BuyReiterates$9+552.17%Dec 18, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.53
from -0.51
EPS Next Year
-0.77
from -0.53
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-78.76K-----19.49M
Revenue Growth
--------
EPS
-0.69-0.73-0.49-0.44-0.51-0.53-0.77-0.19
EPS Growth
--------
Forward PE
--------
No. Analysts
-----443
Financial currency is CAD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a33.9M
Avgn/an/a19.5M
Lown/an/a5.8M

Revenue Growth

Revenue Growth20252026202720282029
High---
Avg---
Low---

EPS Forecast

EPS20252026202720282029
High-0.48-0.57-0.19
Avg-0.53-0.77-0.19
Low-0.56-0.94-0.18

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.